Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Immunoassays › Food Allergy Dx Firm AllerGenis, Luminex Ink Test Development Deal

Food Allergy Dx Firm AllerGenis, Luminex Ink Test Development Deal

Jan 16, 2019
|
staff reporter

NEW YORK (360Dx) – Food allergy diagnostic developer AllerGenis today announced a non-exclusive deal with Luminex for use of that company's xMAP technology to develop, market, and sell a precision food allergy diagnostic assay.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Immunoassays

  1. Report Details COVID-19 Testing Within Federal Government

  2. At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

  3. Ortho Clinical Diagnostics COVID-19 Antigen Test Receives FDA EUA for High-Volume Testing

  4. Chembio Nabs CE Mark for SARS-CoV-2 Tests, Inks Distribution Agreement with Luas Diagnostics

  5. Biomerica Gets CE Mark for Point-of-Care Coronavirus Antigen Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.